Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Paranuclear dot-like cytokeratin MNF116 positivity in cutaneous myoepithelioma.

Luzar B, Calonje E.

J Cutan Pathol. 2013 Nov;40(11):982-4. doi: 10.1111/cup.12211. Epub 2013 Sep 17. No abstract available.

PMID:
24102641
[PubMed - indexed for MEDLINE]
2.

Anti-cytokeratin CAM5.2 (BD Biosciences) and CK8 give no remarkable advantages to the pancytokeratin cocktail of antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in detecting disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients.

Lin WL, Chen FL, Han CP.

Ann Surg Oncol. 2011 Dec;18 Suppl 3:S261-2; author reply S263-4. doi: 10.1245/s10434-010-1419-z. Epub 2010 Dec 2. No abstract available.

PMID:
21125337
[PubMed - indexed for MEDLINE]
3.

Squamous cell carcinomas with single cell infiltration: a potential diagnostic pitfall and the utility of MNF116 and p63.

Ko CJ, McNiff JM, Glusac EJ.

J Cutan Pathol. 2008 Apr;35(4):353-7. doi: 10.1111/j.1600-0560.2007.00808.x.

PMID:
18333895
[PubMed - indexed for MEDLINE]
4.

Expression of cytokeratin MNF116 and vimentin in pleural serous effusions.

Mocanu L, Cîmpean AM, Raica M.

Rom J Morphol Embryol. 2007;48(3):291-4.

PMID:
17914498
[PubMed - indexed for MEDLINE]
Free Article
5.
6.

Immunohistochemical detection of keratin with the monoclonal antibody MNF116 is useful in the diagnosis of epidermolysis bullosa simplex.

Prieto VG, McNutt NS.

J Cutan Pathol. 1994 Apr;21(2):118-22.

PMID:
7518848
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk